Latest News by Industry
WASHINGTON (AP) — WASHINGTON (AP) — Vanda Pharmaceuticals Inc. (VNDA) on Wednesday reported net income of $6.9 million in its fourth quarter.
On a per-share basis, the Washington-based company said it had net income of 12 cents.
The biopharmaceutical company posted revenue of $64.5 million in the period.
For the year, the company reported profit of $6.3 million, or 11 cents per share. Revenue was reported as $254.4 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a VNDA">Zacks stock report on VNDA at https://www.zacks.com/ap/VNDA